Aytu Biopharma (AYTU) Gross Margin Growth (1y) (2015 - 2026)
Powered by 
Analysis
Aytu Biopharma (AYTU) Gross Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.13 Bn | 625.38 Bn | 17.26 Bn | 32.00 |
| 2 | AbbVie | 442.39 Bn | 435.82 Bn | 12.70 Bn | 292.00 |
| 3 | Merck | 366.26 Bn | 359.12 Bn | 12.21 Bn | -396.00 |
| 4 | Novartis Ag | 266.58 Bn | 258.89 Bn | 11.24 Bn | -391.00 |
| 5 | Pfizer | 159.00 Bn | 147.30 Bn | 10.94 Bn | -144.00 |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | 257.00 |
| 7 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 8 | Incyte | 25.41 Bn | 20.87 Bn | 1.57 Bn | 21.00 |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | -173.00 |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -817.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -817.00 |
| Dec 31, 2025 | -303.00 |
| Sep 30, 2025 | -617.00 |
| Jun 30, 2025 | -798.00 |
| Mar 31, 2025 | -447.00 |
| Dec 31, 2024 | -1,140.00 |
| Sep 30, 2024 | -87.00 |
| Jun 30, 2024 | 1,533.00 |
| Mar 31, 2024 | 1,782.00 |
| Dec 31, 2023 | 1,209.00 |
| Sep 30, 2023 | 797.00 |
| Jun 30, 2023 | 633.00 |
| Mar 31, 2023 | 363.00 |
| Dec 31, 2022 | 1,262.00 |
| Sep 30, 2022 | 832.00 |
| Jun 30, 2022 | 596.00 |
| Dec 31, 2021 | -555.00 |
| Sep 30, 2021 | -1,306.00 |
| Jun 30, 2021 | -1,621.00 |
| Dec 31, 2020 | -2,218.00 |